Oral administration of a calcitonin

Details for Australian Patent Application No. 2008223108 (hide)

Owner Novartis AG

Inventors Joshi, Yatindra

Agent Pizzeys

Pub. Number AU-A-2008223108

PCT Pub. Number WO2008/109385

Priority 60/892,594 02.03.07 US

Filing date 29 February 2008

Wipo publication date 12 September 2008

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/109385 Priority application(s): WO2008/109385

10 September 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 Aug 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008223133-Use of copper and glutamate in cell culture for production of polypeptides

2008223091-Sustained release pellets comprising wax-like material